Simulations Plus (SLP) to Release Earnings on Thursday

Simulations Plus (NASDAQ:SLP) is projected to release its Q2 2026 results after the market closes on Thursday, April 9th. Analysts expect Simulations Plus to post earnings of $0.27 per share and revenue of $21.6590 million for the quarter. Interested persons can check the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Thursday, April 2, 2026 at 5:00 PM ET.

Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings results on Thursday, January 8th. The technology company reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.05). The company had revenue of $18.42 million for the quarter, compared to analyst estimates of $18.05 million. Simulations Plus had a positive return on equity of 14.02% and a negative net margin of 81.66%.During the same period last year, the firm earned $0.17 EPS. On average, analysts expect Simulations Plus to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Simulations Plus Stock Up 3.9%

NASDAQ:SLP opened at $12.46 on Tuesday. The firm has a market capitalization of $251.03 million, a price-to-earnings ratio of -3.89 and a beta of 1.19. Simulations Plus has a twelve month low of $11.09 and a twelve month high of $36.45. The stock’s 50 day moving average price is $12.90 and its two-hundred day moving average price is $16.04.

Analysts Set New Price Targets

Several research firms have weighed in on SLP. Wall Street Zen lowered Simulations Plus from a “buy” rating to a “hold” rating in a research report on Saturday. Zacks Research lowered Simulations Plus from a “strong-buy” rating to a “hold” rating in a research report on Monday, February 2nd. TD Cowen reaffirmed a “hold” rating on shares of Simulations Plus in a research report on Thursday, January 8th. BTIG Research lowered Simulations Plus from a “buy” rating to a “neutral” rating in a report on Thursday, December 18th. Finally, Citigroup reissued a “market perform” rating on shares of Simulations Plus in a report on Tuesday, January 6th. Three research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $25.00.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Raymond James Financial Inc. acquired a new position in shares of Simulations Plus during the 2nd quarter worth approximately $25,000. Quarry LP bought a new stake in Simulations Plus in the 3rd quarter valued at $28,000. US Bancorp DE boosted its stake in Simulations Plus by 32.5% in the 3rd quarter. US Bancorp DE now owns 6,167 shares of the technology company’s stock valued at $93,000 after purchasing an additional 1,513 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Simulations Plus by 4.3% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,493 shares of the technology company’s stock valued at $233,000 after purchasing an additional 390 shares during the period. Finally, Price T Rowe Associates Inc. MD bought a new stake in Simulations Plus in the 4th quarter valued at $186,000. 78.08% of the stock is owned by institutional investors and hedge funds.

Simulations Plus Company Profile

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.